187 related articles for article (PubMed ID: 26519864)
1. HLA-G 14 bp insertion/deletion polymorphism and its association with sHLA-G levels in Behçet's disease Tunisian patients.
Sakly K; Maatouk M; Hammami S; Harzallah O; Sakly W; Feki S; Mirshahi M; Ghedira I; Sakly N
Hum Immunol; 2016 Jan; 77(1):90-95. PubMed ID: 26519864
[TBL] [Abstract][Full Text] [Related]
2. High Amounts of Total and Extracellular Vesicle-Derived Soluble HLA-G are Associated with HLA-G 14-bp Deletion Variant in Women with Embryo Implantation Failure.
Nardi Fda S; Slowik R; Michelon T; Manvailer LF; Wagner B; Neumann J; Horn P; Bicalho Mda G; Rebmann V
Am J Reprod Immunol; 2016 Jun; 75(6):661-71. PubMed ID: 26959830
[TBL] [Abstract][Full Text] [Related]
3. The association between functional HLA-G 14bp insertion/deletion and +3142 C>G polymorphisms and susceptibility to multiple sclerosis.
Ben Fredj N; Sakly K; Bortolotti D; Aissi M; Frih-Ayed M; Rotola A; Caselli E; Cura F; Sakly N; Aouni M; Di Luca D; Rizzo R
Immunol Lett; 2016 Dec; 180():24-30. PubMed ID: 27771469
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.
Zidi I; Dziri O; Zidi N; Sebai R; Boujelebene N; Ben Hassine A; Ben Yahia H; Laaribi AB; Babay W; Rifi H; Mezlini A; Chelbi H
Immunol Res; 2016 Aug; 64(4):961-8. PubMed ID: 26754763
[TBL] [Abstract][Full Text] [Related]
5. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.
Zidi I; Ben Yahia H; Bortolotti D; Mouelhi L; Laaribi AB; Ayadi S; Zidi N; Houissa F; Debbech R; Boudabous A; Najjar T; Di Luca D; Rizzo R
Int Immunol; 2015 Jun; 27(6):289-96. PubMed ID: 25577194
[TBL] [Abstract][Full Text] [Related]
6. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3'UTR 14 bp polymorphism and sHLA-G.
Darbas S; Yilmaz VT; Kocak H; Kisaoglu A; Demiryilmaz I; Aydinli B; Arslan HS; Ucar F
Gene; 2021 Jul; 790():145712. PubMed ID: 33984446
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA-G Polymorphisms in the 3'UTR Region and Soluble HLA-G with Kidney Graft Outcome.
Durmanova V; Bandzuchova H; Zilinska Z; Tirpakova J; Kuba D; Buc M; Polakova K
Immunol Invest; 2019 Aug; 48(6):644-658. PubMed ID: 31094243
[No Abstract] [Full Text] [Related]
8. The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.
Capittini C; Bergamaschi P; Sachetto S; Truglio M; Viola M; Marchesi A; Genovese V; Romano B; Guarene M; Poma R; Martinetti M; Tinelli C; Salvaneschi L
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s361-6. PubMed ID: 23399358
[TBL] [Abstract][Full Text] [Related]
9. Association of
Gautam S; Kumar U; Kumar M; Kanga U; Dada R
Immunol Invest; 2020 Feb; 49(1-2):88-105. PubMed ID: 31549885
[No Abstract] [Full Text] [Related]
10. Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G.
Dahl M; Klitkou L; Christiansen OB; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Hviid TV
Hum Immunol; 2015 Apr; 76(4):260-71. PubMed ID: 25637667
[TBL] [Abstract][Full Text] [Related]
11. The Impact of
Ouni N; Chaaben AB; Kablouti G; Ayari F; Douik H; Abaza H; Gara S; Elgaaied-Benammar A; Guemira F; Tamouza R
Immunol Invest; 2019 Jul; 48(5):521-532. PubMed ID: 30945586
[TBL] [Abstract][Full Text] [Related]
12. Gene polymorphism and HLA-G expression in patients with childhood-onset systemic lupus erythematosus: A pilot study.
Cavalcanti A; Almeida R; Mesquita Z; Duarte ALBP; Donadi EA; Lucena-Silva N
HLA; 2017 Oct; 90(4):219-227. PubMed ID: 28695673
[TBL] [Abstract][Full Text] [Related]
13. The HLA-G 14 bp insertion/deletion polymorphism and its association with soluble HLA-G levels in women with recurrent miscarriages.
Kalotra V; Lall M; Verma IC; Kaur A; Kaur A
HLA; 2018 Mar; 91(3):167-174. PubMed ID: 29280596
[TBL] [Abstract][Full Text] [Related]
14. 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis.
Tizaoui K; Jalouli M; Ouzari HI; Harrath AH; Rizzo R; Boujelbene N; Zidi I
Immunol Lett; 2022 Aug; 248():78-89. PubMed ID: 35752280
[TBL] [Abstract][Full Text] [Related]
15. Plasma soluble HLA-G levels in a cohort of heart failure patients exposed to chemicals.
Bortolotti D; Vitali E; Stendardo M; Fucili A; Rizzo R; Boschetto P
Hum Immunol; 2020 Apr; 81(4):151-155. PubMed ID: 31806379
[TBL] [Abstract][Full Text] [Related]
16. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population.
Martelli-Palomino G; Pancotto JA; Muniz YC; Mendes-Junior CT; Castelli EC; Massaro JD; Krawice-Radanne I; Poras I; Rebmann V; Carosella ED; Rouas-Freiss N; Moreau P; Donadi EA
PLoS One; 2013; 8(10):e71742. PubMed ID: 24204558
[TBL] [Abstract][Full Text] [Related]
17. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease.
Misra MK; Prakash S; Kapoor R; Pandey SK; Sharma RK; Agrawal S
Tissue Antigens; 2013 Nov; 82(5):317-26. PubMed ID: 24131018
[TBL] [Abstract][Full Text] [Related]
18. [Association of HLA-G 14bp gene polymorphisms and plasma sHLA-G level with susceptibility to EV71 infection in children].
Chen XQ; Wang HY; Gao Y; Yu LL; Chen D; Zheng XQ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):429-31. PubMed ID: 23627021
[TBL] [Abstract][Full Text] [Related]
19. HLA-G UTR haplotype conservation in the Malian population: association with soluble HLA-G.
Carlini F; Traore K; Cherouat N; Roubertoux P; Buhler S; Cortey M; Simon S; Doumbo O; Chiaroni J; Picard C; Di Cristofaro J
PLoS One; 2013; 8(12):e82517. PubMed ID: 24376542
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G levels in seminal plasma are associated with HLA-G 3'UTR genotypes and haplotypes.
Craenmehr MHC; Haasnoot GW; Drabbels JJM; Spruyt-Gerritse MJ; Cao M; van der Keur C; Kapsenberg JM; Uyar-Mercankaya M; van Beelen E; Meuleman T; van der Hoorn MP; Heidt S; Claas FHJ; Eikmans M
HLA; 2019 Oct; 94(4):339-346. PubMed ID: 31321883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
